Nutrition 21, Inc. 

(Public, OTC:NXXI)   Watch this stock   
Find more results for NXXI
Nov 12, 2009
Q1 2010 Earnings Release
  

Key stats and ratios

Q3 (Sep '09) 2009
Net profit margin -13.87% -52.54%
Operating margin 7.68% -43.91%
EBITD margin - -41.06%
Return on average assets -18.93% -76.43%
Return on average equity - -
Employees 20 -

Address

4 Manhattanville Road
Purchase, NY 10577
United States - Map
+1-914-7014500 (Phone)
+1-914-6960863 (Fax)

Website links

Nutrition 21, Inc. discussions

  View all discussions »

Description

Nutrition 21, Inc. is a nutritional bioscience company and the marketer of Chromax chromium picolinate products and Iceland Health omega-3 fish oil-based supplements with health benefits substantiated by clinical research. The Company also creates and develops nutritional supplement ingredients and formulations for sale and licensing to marketers of nutritional supplement products to be used in their finished products. Its products are sold and distributed through two operating segments: Ingredients and Branded Products. It sometimes refers to its Branded Products segment as its Consumer Health segment. The Ingredients segment markets and sells to other marketers and distributors of various nutritional supplement products in both the human and animal nutrition markets. The Consumer Health segment develops, markets and sells finished nutritional supplement products directly to consumers and through mass retail channels.

Officers and directors

John H. Gutfreund
Chairman of the Board
Age: 79
Michael A. Zeher
President, Chief Executive Officer, Director
Age: 61
Alan J. Kirschbaum
Chief Financial Officer, Vice President - Finance and Treasury, Principal Accounting Officer
Portrait. Age: 63
Pam McWilliams
Vice President, General Manager - Direct Response Group
P. George Benson Ph.D.
Director
Age: 62
Warren D. Cooper M.D.
Director
Age: 55
John L. Cassis
Director
Age: 60
Peter C. Mann
Director
Age: 67